A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: A children's oncology group study
2007 ◽
Vol 110
(11)
◽
pp. 2535-2541
◽
Maryam Fouladi
◽
H. Stacy Nicholson
◽
Tianni Zhou
◽
Fred Laningham
◽
Kathleen J. Helton
◽
...